FineMedix Co (387570.KQ) Stock Price

FineMedix Co Price

CLOSED
6,000.00
​
Market closed

Over the last 3 years FineMedix Co grew revenue by 6.1% annually, reaching 9.43 B KRW. For FineMedix Co, the net margin of -19.9% is down versus 3.0% a few years ago.

FineMedix Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FineMedix Co business model & stock analysis

FineMedix Co Ltd is a KR-based company operating in industry. The company is headquartered in Daegu, Daegu. The company went IPO on 2024-12-26. Finemedix Co Ltd is a Korea-based company primarily engaged in the medical devices manufacturing and sales business. The firm mainly engages in the microinvasive medical devices such as therapeutic endoscopes and diagnostic endoscopes. The firm also provides endoscopic surgery devices such as knives, injectors, baskets, Endoscopic clips as well as snares for endoscopic submucosal (ESD) dissection and endoscopic mucosal resection (EMR).

Frequently asked questions about FineMedix Co

Converted at the current exchange rate, the FineMedix Co share trades at 3.98 EUR (6,000.00 KRW).

The revenue cannot currently be calculated for FineMedix Co.

The profit cannot currently be calculated for FineMedix Co.

The P/E ratio cannot be calculated for FineMedix Co at the moment.

The P/S cannot be calculated for FineMedix Co currently.

The Eulerpool Quality Score for FineMedix Co is 2/10.

The ISIN of FineMedix Co is KR7387570005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of FineMedix Co is 387570.KQ. The ticker symbol is used to trade FineMedix Co shares on the stock exchange.

Fair ValueTerminal
4,920.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 26, 2024
ISIN
KR7387570005
Market capitalization
27.22 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.43
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-9.05 %
Last updated Oct 16, 2026, 6:24 PM

FineMedix Co Peer Group